RT Journal Article
SR Electronic
T1 COVID-19 and children with cancer: Parents’ experiences, anxieties, and support needs
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.11.20128603
DO 10.1101/2020.06.11.20128603
A1 Darlington, Anne-Sophie E
A1 Morgan, Jessica E
A1 Wagland, Richard
A1 Sodergren, Samantha
A1 Culliford, David
A1 Gamble, Ashley
A1 Phillips, Bob
YR 2020
UL http://medrxiv.org/content/early/2020/06/12/2020.06.11.20128603.abstract
AB Background Children with cancer were considered to be extremely clinically vulnerable to severe COVID-19 disease if they were to contract SARS-CoV-2 due to immune suppression as a result of anti-cancer treatment. The aim was to explore experiences, information and support needs, and decision-making of parents with a child with cancer in response to the early phase of the COVID-19 pandemic in the UK.Methods Parents of a child with cancer completed a survey in April 2020, as the UK moved into a period of ‘lockdown’, with restrictions of movement outside of the home. An online survey was developed to capture parents’ experiences, information and support needs, and decision-making, using closed statements and open text boxes. Descriptive quantitative analyses and qualitative thematic content analysis were undertaken.Findings 171 parents/caregivers completed the survey. 85% of parents worried about the virus and the majority of parents were vigilant about virus (92%) or cancer symptoms (93.4%). For two-thirds (69.6%) hospital was no longer considered a safe place. Parents worried about their own health (81.1%) and about the child getting the virus from them (89.1%). Eight overarching themes, related to the virus: 1) risk of infection, 2) information, guidance and advice, 3) health care provision, 4) fears and anxieties; or related to lockdown/isolation: 5) psychological and social impact, 6) keeping safe under lockdown, 7) provisions and dependence, and 8) employment and income.Interpretation This is the first study to report experiences of parents of a child with cancer during the SARS-CoV-2/COVID-19 pandemic. The study demonstrated that the majority of parents are worried about SARS-CoV-2, and worried about transmitting the virus to their child. Hospital was no longer a safe place, and parents were worried about suboptimal cancer care. Parents describe fear and anxiety and the psychological, social and economic impact of isolation as a family.RESEARCH INTO CONTEXTEvidence before this studyEvidence before this study Quarantine due to a pandemic can be traumatic for families. No evidence exists about experiences of families with a clinically vulnerable child with possible increased risk of SARS-CoV-2 infection.Added value of this studyAdded value of this study Insight into high levels of worry about the child with cancer becoming infected by parents, healthcare professionals, or from a hospital visit. Increased vigilance of symptoms, fear and anxiety, psychological impact of isolation, and the need for clear information and guidance.Implications of all available evidenceImplications of all available evidence Understanding parents’ worries and needs can shape information provision and guidance, and inclusion of vulnerable children in national policy.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementThis study was in part supported by the Children's Cancer and Leukaemia Group (CCLG)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Southampton and UK NHS Health Research Authority Research Ethics Committees (IRAS nr. 282176)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymised, non-identifiable data will be available for collaborative projects